Study: Enhanced PET-CT technology driving demand

The improved capabilities of fused positron emission tomography (PET-CT) technology is increasing demand within the diagnostic imaging market, according to new a U.S. PET and PET-CT Markets study released by Frost & Sullivan.
   
Stand-alone PET systems are now undergoing a drop in market activity as a result of the capabilities of the hybrid systems, which are effective in detecting cancers that are hard to localize, and are powerful tools for disease management and therapy planning, according to the analysis, Frost & Sullivan said.
   
Additional analysis showed that lower-cost stand-alone PET systems available within the used market is also hurting sales of new stand-alone PET systems, which is creating an environment of tough competition among companies.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.